Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Vesiculobullous
Description
Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990) MeSH
Hierarchy View
Subtype Terms (13)
Blister
5 drugs (4 approved, 1 experimental)
Dermatitis Herpetiformis
9 drugs (7 approved, 2 experimental)
Eczema, Dyshidrotic
1 experimental drug
Epidermolysis Bullosa
49 drugs (22 approved, 27 experimental)
Erythema Multiforme
4 approved drugs
Linear IgA Bullous Dermatosis
3 drugs (1 approved, 2 experimental)
Pemphigoid, Benign Mucous Membrane
8 drugs (6 approved, 2 experimental)
Pemphigoid, Bullous
30 drugs (22 approved, 8 experimental)
Pemphigoid Gestationis
1 experimental drug
Pemphigus
37 drugs (23 approved, 14 experimental)
Pemphigus, Benign Familial
1 approved drug
Phase 4 Indicated Drugs (2)
Organization Involved with Phase 4 Indications (15)
Organization Involved with Phase 1 Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
